In addition to assuring a constant and ready supply to wholesale distributors and providing ordering instructions to all retail pharmacies, Aton Pharma is supporting Lacrisert with a reimbursement assistance help line and other resources.
Lacrisert is a unique preservative-free, once-daily, sustained release prescription insert that helps to retain moisture, stabilize the tear film, and lubricate the eye.
Michael Wells, CEO of Aton Pharma, said: “As part of Aton’s mission to ensure patient access to important therapies, we have established supply chain and commercialization processes to make certain Lacrisert is well-supported and readily available to patients. As a company specializing in essential treatments for under-treated diseases, we are proud to provide a therapeutic option for dry eye with a strong history of effectiveness and safety.”